5 research outputs found
A Biodegradation Study of SBA-15 Microparticles in Simulated Body Fluid and <i>in Vivo</i>
Mesoporous silica has received considerable
attention as a drug
delivery vehicle because of its large surface area and large pore
volume for loading drugs and large biomolecules. Recently, mesoporous
silica microparticles have shown potential as a three-dimensional
vaccine platform for modulating dendritic cells via spontaneous assembly
of microparticles in a specific region after subcutaneous injection.
For further <i>in vivo</i> applications, the biodegradation
behavior of mesoporous silica microparticles must be studied and known.
Until now, most biodegradation studies have focused on mesoporous
silica nanoparticles (MSNs); here, we report the biodegradation of
hexagonally ordered mesoporous silica, SBA-15, with micrometer-sized
lengths (∼32 μm with a high aspect ratio). The degradation
of SBA-15 microparticles was investigated in simulated body fluid
(SBF) and in mice by analyzing the structural change over time. SBA-15
microparticles were found to degrade in SBF and <i>in vivo</i>. The erosion of SBA-15 under biological conditions led to a loss
of the hysteresis loop in the nitrogen adsorption/desorption isotherm
and fingerprint peaks in small-angle X-ray scattering, specifically
indicating a degradation of ordered mesoporous structure. Via comparison
to previous results of degradation of MSNs in SBF, SBA-15 microparticles
degraded faster than MCM-41 nanoparticles presumably because SBA-15
microparticles have a pore size (∼8 nm) and a pore volume larger
than those of MCM-41 mesoporous silica. The surface functional groups,
the residual amounts of organic templates, and the hydrothermal treatment
during the synthesis could affect the rate of degradation of SBA-15.
In <i>in vivo</i> testing, previous studies focused on the
evaluation of toxicity of mesoporous silica particles in various organs.
In contrast, we studied the change in the physical properties of SBA-15
microparticles depending on the duration after subcutaneous injection.
The pristine SBA-15 microparticles injected into mice subcutaneously
slowly degraded over time and lost ordered structure after 3 days.
These findings represent the possible <i>in vivo</i> use
of microsized mesoporous silica for drug delivery or vaccine platform
after local injection
Aspartic Acid-Assisted Synthesis of Multifunctional Strontium-Substituted Hydroxyapatite Microspheres
Strontium-substituted hydroxyapatite
(SrHAP) microspheres with
three-dimensional (3D) structures were successfully prepared via hydrothermal
method using self-assembled polyÂ(aspartic acid) (PASP) as a template.
By controlling various parameters, including hydrothermal reaction
time, amount of l-aspartic acid (l-Asp), and ratio
of Sr ions, we were able to investigate the influences of the additive l-Asp on morphology and properties of final products as well
as the role of self-assembled PASP template on the formation of HAP
microspheres. The change in the amount of Sr substitution significantly
affected the particle size, morphology, and concurrent surface area.
This difference caused variation in the drug-release properties. In
addition, substitution of Sr ions into Ca ion sites affected luminescence
of HAP powders. Particularly, multifunctional SrHAP with molar ratios
(Sr/[Ca+Sr]) of 0.25 possessed the strongest luminescence as well
as superior drug-loading and sustained-releasing properties. These
properties were associated with large surface area and large pore
size of the SrHAP. This study suggests that the optical and structural
properties of the HAP particles can be carefully tuned by controlling
the amount of Sr ions doped into HAP particles during synthesis. This
work provides new opportunities to synthesize HAP particles suitable
for diverse applications including bone regeneration and drug delivery
Flexible and Transparent Metallic Grid Electrodes Prepared by Evaporative Assembly
We propose a novel approach to fabricating
flexible transparent
metallic grid electrodes via evaporative deposition involving flow-coating.
A transparent flexible metal grid electrode was fabricated through
four essential steps including: (i) polymer line pattern formation
on the thermally evaporated metal layer onto a plastic substrate;
(ii) rotation of the stage by 90° and the formation of the second
polymer line pattern; (iii) etching of the unprotected metal region;
and (iv) removal of the residual polymer from the metal grid pattern.
Both the metal grid width and the spacing were systematically controlled
by varying the concentration of the polymer solution and the moving
distance between intermittent stop times of the polymer blade. The
optimized Au grid electrodes exhibited an optical transmittance of
92% at 550 nm and a sheet resistance of 97 Ω/sq. The resulting
metallic grid electrodes were successfully applied to various organic
electronic devices, such as organic field-effect transistors (OFETs),
organic light-emitting diodes (OLEDs), and organic solar cells (OSCs)
Direct Observation of Nanoparticle–Cancer Cell Nucleus Interactions
We report the direct visualization of interactions between drug-loaded nanoparticles and the cancer cell nucleus. Nanoconstructs composed of nucleolin-specific aptamers and gold nanostars were actively transported to the nucleus and induced major changes to the nuclear phenotype <i>via</i> nuclear envelope invaginations near the site of the construct. The number of local deformations could be increased by ultrafast, light-triggered release of the aptamers from the surface of the gold nanostars. Cancer cells with more nuclear envelope folding showed increased caspase 3 and 7 activity (apoptosis) as well as decreased cell viability. This newly revealed correlation between drug-induced changes in nuclear phenotype and increased therapeutic efficacy could provide new insight for nuclear-targeted cancer therapy
Ultrastable-Stealth Large Gold Nanoparticles with DNA Directed Biological Functionality
The stability of gold nanoparticles
(AuNPs) in biological samples
is very important for their biomedical applications. Although various
molecules such as polystyrenesulfonate (PSS), phosphine, DNA, and
polyethylene glycol (PEG) have been used to stabilize AuNPs, it is
still very difficult to stabilize large AuNPs. As a result, biomedical
applications of large (30–100 nm) AuNPs are limited, even though
they possess more favorable optical properties and are easier to be
taken up by cells than smaller AuNPs. To overcome this limitation,
we herein report a novel method of preparing large (30–100
nm) AuNPs with a high colloidal stability and facile chemical or biological
functionality, via surface passivation with an amphiphilic polymer
polyvinylpyrrolidone (PVP). This PVP passivation results in an extraordinary
colloidal stability for 13, 30, 50, 70, and 100 nm AuNPs to be stabilized
in PBS for at least 3 months. More importantly, the PVP capped AuNPs
(AuNP-PVP) were also resistant to protein adsorption in the presence
of serum containing media and exhibit a negligible cytotoxicity. The
AuNP-PVPs functionalized with a DNA aptamer AS1411 remain biologically
active, resulting in significant increase in the uptake of the AuNPs
(∼12 200 AuNPs per cell) in comparison with AuNPs capped
by a control DNA of the same length. The novel method developed in
this study to stabilize large AuNPs with high colloidal stability
and biological activity will allow much wider applications of these
large AuNPs for biomedical applications, such as cellular imaging,
molecular diagnosis, and targeted therapy